Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/Helus Pharma Inc./ 3

Initial Beneficial Ownership · 3

Helus Pharma Inc.

Initial Beneficial Ownership

Filed Oct 23, 2026Accepted Oct 23, 2026, 7:13 PM EDTFiling CIK 1833141Accession 0000912282-26-001380
View company →Permanent SEC source ↗
Share

Structured filing — 3

form3.xml

Open full document ↗

Filing details

Report period
2026-10-13
Issuer
Helus Pharma Inc.
Issuer CIK
0001833141
Trading symbol
HELP

Reporting owner 1

Name
Lawson Mark
Reporting owner CIK
0001438216
Relationship
Director
Address
C/O HELUS PHARMA INC., 100 KING STREET WEST, SUITE 5600, TORONTO, ONTARIO, CANADA, A6, M5X 1C9

Non-derivative holdings

Non-derivative holdings · 2 reported rows
SecurityAmount ownedOwnershipNature of ownership
Common Shares3,026D
Common Shares157,000IHeld by Four Paths Partners Ltd.[F1]
Table key
D
Direct
I
Indirect

Footnotes

F1
Held by Four Paths Partners Ltd., a corporation owned and controlled by the reporting person.↩ 1

Signature 1

Signed
/s/ Mark Lawson
Date
2026-10-23

Company context

Current securities

HELPNASDAQ · EQUITY · CurrentHELPNEO · EQUITY · Current
Historical securities (2)
CYBNNYSE_AMERICAN · EQUITY · Historical · closed Jan 2, 2026HELPCSE · EQUITY · Historical · closed Mar 29, 2022

Recent company filings

  1. 6-K filingOct 27, 2026
  2. 3 filingOct 26, 2026
  3. 6-K filingOct 21, 2026
  4. 6-K filingOct 15, 2026
  5. 6-K filingOct 8, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.